RFG Advisory’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-773
| Closed | -$277K | – | 649 |
|
|
2023
Q3 | $277K | Sell |
773
-37
| -5% | -$13.3K | 0.01% | 527 |
|
|
2023
Q2 | $307K | Sell |
810
-2
| -0.2% | -$758 | 0.01% | 520 |
|
|
2023
Q1 | $389K | Sell |
812
-11
| -1% | -$5.27K | 0.02% | 461 |
|
|
2022
Q4 | $388K | Buy |
823
+99
| +14% | +$46.6K | 0.02% | 462 |
|
|
2022
Q3 | $277K | Buy |
724
+70
| +11% | +$26.8K | 0.02% | 503 |
|
|
2022
Q2 | $353K | Sell |
654
-28
| -4% | -$15.1K | 0.02% | 428 |
|
|
2022
Q1 | $384K | Buy |
682
+79
| +13% | +$44.5K | 0.02% | 375 |
|
|
2021
Q4 | $456K | Sell |
603
-71
| -11% | -$53.7K | 0.03% | 319 |
|
|
2021
Q3 | $503K | Sell |
674
-101
| -13% | -$75.4K | 0.04% | 273 |
|
|
2021
Q2 | $499K | Sell |
775
-20
| -3% | -$12.9K | 0.04% | 267 |
|
|
2021
Q1 | $454K | Sell |
795
-7
| -0.9% | -$4K | 0.05% | 271 |
|
|
2020
Q4 | $498K | Sell |
802
-64
| -7% | -$39.7K | 0.07% | 246 |
|
|
2020
Q3 | $446K | Buy |
866
+68
| +9% | +$35K | 0.06% | 246 |
|
|
2020
Q2 | $360K | Buy |
798
+136
| +21% | +$61.4K | 0.06% | 253 |
|
|
2020
Q1 | $232K | Buy |
+662
| New | +$232K | 0.04% | 300 |
|